Lanxess (LXS) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
9 Jul, 2026Executive summary
Q3 2025 sales declined 16.3% year-over-year to €1,338 million, driven by weak demand, negative currency effects, and portfolio changes, including the Urethane Systems divestment.
EBITDA pre exceptionals fell 27.7% to €125 million, with margin dropping to 9.3% from 10.8%.
Net income was negative at €77 million, compared to €1 million in Q3 2024; adjusted EPS was minus €0.07 versus €0.86 prior year.
Cost reduction programs (~€100 million), hiring freeze, and production efficiencies were implemented to offset declines.
Persistently challenging market conditions, especially in agrochemical and construction sectors, impacted performance.
Financial highlights
Gross profit decreased 27.2% year-over-year to €254 million.
Operating result (EBIT) was negative €28 million, down from €24 million in Q3 2024.
Cash flow from operating activities was €50 million, down 15.3% year-over-year.
Free cash flow for the first nine months was minus €94 million, compared to minus €18 million prior year.
Net financial liabilities reduced to €2,072 million from €2,381 million at year-end 2024; equity ratio improved to 48%.
Outlook and guidance
Full-year 2025 EBITDA pre exceptionals expected at the lower end of €520–580 million range.
Q4 expected to be seasonally weaker than Q3, with no EBITDA contribution from Urethane Systems.
German government stimulus and anti-dumping measures expected to support results from H2 2026, especially in construction-related units.
Persistent macroeconomic uncertainties and excess Asian capacity remain key challenges.
Latest events from Lanxess
- EBITDA pre rose 32% to €133m, guidance held, and Urethane sale proceeds to reduce debt.LXS
Q1 20258 Jul 2026 - Sales and EBITDA fell, debt reduced, and EUR 100M cost savings with 550 job cuts announced.LXS
Q4 2025 (Media)8 Jul 2026 - Sales and earnings fell, but debt reduction, restructuring, and sustainability drive resilience.LXS
AGM 202621 May 2026 - Sales and EBITDA fell sharply, but full-year guidance is maintained amid persistent market headwinds.LXS
Q1 2026 (Media)12 May 2026 - Sales and EBITDA dropped, but full-year guidance is confirmed and Q2 is set to improve.LXS
Q1 20267 May 2026 - 2026 EBITDA guidance is €450–550 million, with recovery expected in H2 2026.LXS
Q4 202519 Mar 2026 - Earnings rose, costs fell, and sustainability advanced amid global uncertainty and strategic refocus.LXS
AGM 20253 Feb 2026 - Q2 2024 EBITDA pre exceptionals surged 69% year-over-year despite lower sales.LXS
Q2 20241 Feb 2026 - EBITDA pre exceptionals jumped 45% and net income returned to profit in Q3 2024.LXS
Q3 202416 Jan 2026